Platelet-active drugs : the relationships among dose, effectiveness, and side effects

Chest. 2001 Jan;119(1 Suppl):39S-63S. doi: 10.1378/chest.119.1_suppl.39s.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Aspirin / pharmacokinetics
  • Aspirin / therapeutic use*
  • Cyclooxygenase Inhibitors / therapeutic use
  • Dipyridamole / therapeutic use
  • Female
  • Fibrinolytic Agents / pharmacokinetics
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors
  • Pre-Eclampsia / prevention & control
  • Pregnancy
  • Thrombosis / prevention & control*

Substances

  • Cyclooxygenase Inhibitors
  • Fibrinolytic Agents
  • Platelet Aggregation Inhibitors
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Dipyridamole
  • Aspirin